We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+31.28%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.82B
AUM Growth
+$324M
Cap. Flow
-$120M
Cap. Flow %
-6.62%
Top 10 Hldgs %
36.31%
Holding
2,419
New
1,036
Increased
430
Reduced
305
Closed
497

Sector Composition

Rank Sector Weight
1 Technology 6.98%
2 Consumer Discretionary 5.02%
3 Healthcare 3.42%
4 Financials 2.97%
5 Industrials 2.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
26
PUT
Apple
AAPL
$4.56T
$8.43M 0.46%
92,400
+27,200
+42% +$2.11M
QQQ icon
27
Invesco QQQ Trust
QQQ
$479B
$8.38M 0.46%
+33,862
New +$7.59M
INTC icon
28
PUT
Intel
INTC
$503B
$8.38M 0.46%
140,000
+139,600
+34,900% +$8.35M
SE icon
29
CALL
Sea Limited
SE
$68B
$8.04M 0.44%
+75,000
New +$5.43M
SE icon
30
PUT
Sea Limited
SE
$68B
$8.04M 0.44%
+75,000
New +$5.43M
IBKC
31
DELISTED
IBERIABANK Corp
IBKC
$7.95M 0.44%
174,622
+3,980
+2% +$164K
MSFT icon
32
Microsoft
MSFT
$3.71T
$7.46M 0.41%
36,682
-2,065
-5% -$375K
TMUS icon
33
T-Mobile US
TMUS
$193B
$7.38M 0.41%
70,846
+31,820
+82% +$3.05M
ACIA
34
DELISTED
Acacia Communications Inc
ACIA
$7.37M 0.41%
109,754
+54,824
+100% +$3.72M
CZR
35
DELISTED
Caesars Entertainment Corporation
CZR
$7.02M 0.39%
+578,909
New +$5.85M
IBB icon
36
CALL
iShares Biotechnology ETF
IBB
$9.53B
$6.89M 0.38%
+55,700
New +$7.1M
SLV icon
37
CALL
iShares Silver Trust
SLV
$29.8B
$6.67M 0.37%
391,900
+101,100
+35% +$1.55M
EEM icon
38
PUT
iShares MSCI Emerging Markets ETF
EEM
$29.2B
$6.63M 0.37%
166,300
+84,800
+104% +$3.17M
CLX icon
39
PUT
Clorox
CLX
$12.8B
$6.58M 0.36%
+30,000
New +$5.99M
CRM icon
40
CALL
Salesforce
CRM
$153B
$6.41M 0.35%
+34,200
New +$5.76M
NVDA icon
41
CALL
NVIDIA
NVDA
$5.3T
$6.34M 0.35%
+668,000
New +$5.4M
FSCT
42
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
$6.27M 0.35%
295,846
+81,969
+38% +$2.23M
DIS icon
43
CALL
Walt Disney
DIS
$181B
$6.17M 0.34%
55,300
+51,300
+1,283% +$5.66M
WYNN icon
44
CALL
Wynn Resorts
WYNN
$10.5B
$6.06M 0.33%
81,400
+79,300
+3,776% +$6.36M
C icon
45
CALL
Citigroup
C
$224B
$6.05M 0.33%
118,500
+48,400
+69% +$2.3M
AVGO icon
46
PUT
Broadcom
AVGO
$2T
$6.03M 0.33%
+191,000
New +$5.35M
SCO icon
47
PUT
ProShares UltraShort Bloomberg Crude Oil
SCO
$726M
$5.8M 0.32%
+2,219
New +$5.25M
AVGO icon
48
Broadcom
AVGO
$2T
$5.75M 0.32%
+182,110
New +$5.1M
WMGI
49
DELISTED
Wright Medical Group Inc
WMGI
$5.65M 0.31%
190,187
+64,474
+51% +$1.89M
HCA icon
50
CALL
HCA Healthcare
HCA
$88.5B
$5.58M 0.31%
+57,500
New +$5.98M

Similar funds

Prelude Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Prelude Capital Management held 2,419 positions worth $1.82B, up 22% from $1.49B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Prelude Capital Management withdrew a net $120M in Q2 2020, closing 497 positions and reducing 305 holdings. Its most notable exit was Allergan plc, an estimated $16.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7% of assets, up from 6.3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in iShares 0-5 Year High Yield Corporate Bond ETF worth $24.4M.

  • Prelude Capital Management's largest Q2 2020 buy was iShares 0-5 Year High Yield Corporate Bond ETF: 568,440 shares worth $24.4M.
  • Prelude Capital Management added most to Acacia Communications Inc in Q2 2020, an estimated $3.72M increase.
  • Prelude Capital Management's biggest Q2 2020 reduction was Micron Technology, cutting an estimated $8.71M.
  • Prelude Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $16.1M.
  • Prelude Capital Management's ten largest holdings make up 36% of its $1.82B portfolio in Q2 2020.
  • Prelude Capital Management opened 1,036 new positions and closed 497 in Q2 2020.
  • Prelude Capital Management's portfolio value rose 22% quarter-over-quarter to $1.82B.

Based on Prelude Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.